Related Experiment Video
Updated: Aug 31, 2025

Dynamic Digital Biomarkers of Motor and Cognitive Function in Parkinson's Disease
Published on: July 24, 2019
Classification of Parkinson's disease and its stages using machine learning
John Michael Templeton1, Christian Poellabauer2, Sandra Schneider3
1Department of Computing and Information Sciences, Florida International University, Miami, FL, 33199, USA. jtemplet@fiu.edu.
Machine learning accurately differentiates Parkinson's disease (PD) from controls and stages using tablet-based neurocognitive tests. Sensor data reveals distinct motor, accuracy, and timing features, offering insights beyond traditional assessments.
Area of Science:
- Digital Health
- Machine Learning
- Neuroscience
Background:
- Digital health technology generates vast data, necessitating advanced analysis methods like machine learning (ML).
- Parkinson's disease (PD) diagnosis and staging traditionally rely on clinical assessments and questionnaires, which may not capture the full spectrum of neurocognitive changes.
- Understanding neurocognitive function in PD is crucial for disease management and technological development.
Purpose of the Study:
- To employ ML classification for assessing the utility of tablet-based neurocognitive features and self-reported metrics in relation to PD and its Hoehn and Yahr (H&Y) stages.
- To compare perceived versus sensor-based neurocognitive abilities in individuals with PD.
- To identify significant neurocognitive features for PD detection and staging.
Main Methods:
- 75 participants (PD and controls) completed 14 tablet-based neurocognitive tests, functional movement assessments, and health questionnaires.
- Decision tree classification was used to analyze sensor-based neurocognitive features and self-reported metrics.
- Feature significance was determined for discriminating PD from controls and early from advanced PD stages.
Main Results:
- ML classification accurately distinguished PD from healthy controls ([Formula: see text]) and differentiated early from advanced PD stages ([Formula: see text]).
- Sensor-based features, particularly device acceleration magnitude, were highly significant across multiple tests.
- Perceived neurocognitive function differed from sensor-based measures, with early-stage PD patients underestimating and advanced-stage patients overestimating certain abilities.
Conclusions:
- ML applied to digital health assessments provides a robust method for PD detection and staging, outperforming traditional tools.
- Sensor-based neurocognitive features offer valuable, objective data for understanding PD progression.
- Discrepancies between perceived and sensor-based abilities highlight the need for tailored digital health technology configurations in PD management.
Related Concept Videos
Parkinson's Disease: Overview
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Neural Regulation
Classification of Illness
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
EPS and iPS Cells in Disease Research

